Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 9/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 1.00 |
| ▸ | CHRNB2 | P17787 | 1/20 | 1.00 |
| ▸ | CHRNB4 | P30926 | 1/20 | 1.00 |
| ▸ | CHRNA3 | P32297 | 1/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.75 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.75 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.56 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ibogaine SCHEMBL31738807 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL32677903 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL10035903 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL14964144 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL14664380 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL32677904 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL23925532 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL4400751 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL21333266 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| Ibogaine SCHEMBL31166257 | 1.00 | SLC6A4 (1.00) | SLC6A4SIGMAR1CHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3707 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735008-A1 | IBOGAINE TREATMENT | Ambio Life Sciences Inc. (CA) | 2026-05-06 | — | — | EP | claimed |
| EP-4727557-A1 | IBOGAINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | Ambio Life Sciences Inc. (CA) | 2026-04-22 | — | — | EP | claimed |
| EP-4358962-B1 | TREATMENT FOR AUTOIMMUNE DISEASES COMPRISING NALTREXONE OR A METABOLITE OR ANALOG THEREOF, A CANNABINOID AND A 5-HT RECEPTOR AGONIST | LDN PHARMA LTD (GB) | 2026-02-04 | — | — | EP | claimed |
| US-12539337-B2 | Nanostructure conjugates for modulation of location-specific subtypes of receptors and ion channels | Molokanova, Elena (US) | 2026-02-03 | — | — | US | claimed |
| WO-2025264860-A2 | METHODS OF TREATING POST-COVID AIRWAY DISEASE | YALE UNIVERSITY (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4665348-A1 | COMPOSITIONS COMPRISING IBOGAINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Labs Corp. (CA) | 2025-12-24 | — | — | EP | claimed |
| EP-4656639-A1 | METHOD FOR THE PREPARATION OF IBOGAMINE AND PURIFICATION OF IBOGAMINE AND IBOGAMINE-TYPE COMPOUNDS | Oeri, Hans (CA) | 2025-12-03 | — | — | EP | claimed |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | claimed |
| US-20250360150-A1 | METHODS OF USING NEUROPLASTIC AGENTS AND TERRAFORMING MARS | BRANNOCK METCALF MOLLY CAROLINE (US) | 2025-11-27 | — | — | US | claimed |
| WO-2025230894-A1 | SALT FORMS OF IBOGAINE | ATAI THERAPEUTICS, INC. (US) | 2025-11-06 | — | — | WO | claimed |
| US-5152994-A | RAPID METHOD FOR INTERRUPTING OR ATTENUATING POLY-DRUG DEPENDENCY SYNDROMES | ADDICTION RESEARCH INSTITUTE, INC. | 1992-10-06 | — | — | US | claimed |
| WO-1991018609-A1 | A RAPID METHOD FOR INTERRUPTING OR ATTENUATING POLY-DRUG DEPENDENCY SYNDROMES | NDA INTERNATIONAL, INC. (US) | 1991-12-12 | — | — | WO | claimed |
| US-5026697-A | Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome | NDA INTERNATIONAL, INC. (US) | 1991-06-25 | — | — | US | claimed |
| EP-0163697-B1 | A RAPID METHOD FOR INTERRUPTING THE NARCOTIC ADDICTION SYNDROME | LOTSOF, Howard S. (US) | 1990-05-23 | — | — | EP | claimed |
| US-4857523-A | Rapid method for attenuating the alcohol dependency syndrome | NDA INTERNATIONAL, INC. (US) | 1989-08-15 | — | — | US | claimed |
| US-4587243-A | Rapid method for interrupting the cocaine and amphetamine abuse syndrome | ADDICTION RESEARCH INSTITUTE, INC. | 1986-05-06 | — | — | US | claimed |
| EP-0163697-A4 | A RAPID METHOD FOR INTERRUPTING THE NARCOTIC ADDICTION SYNDROME. | LOTSOF HOWARD S | 1986-04-15 | — | — | EP | claimed |
| EP-0163697-A1 | A RAPID METHOD FOR INTERRUPTING THE NARCOTIC ADDICTION SYNDROME. | LOTSOF HOWARD S | 1985-12-11 | — | — | EP | claimed |
| WO-1985002115-A1 | A RAPID METHOD FOR INTERRUPTING THE NARCOTIC ADDICTION SYNDROME | LOTSOF HOWARD S (US) | 1985-05-23 | — | — | WO | claimed |
| US-4499096-A | Rapid method for interrupting the narcotic addiction syndrome | ADDICTION RESEARCH INSTITUTE, INC. | 1985-02-12 | — | — | US | claimed |